Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
McKesson
AstraZeneca
Colorcon
Dow

Last Updated: January 27, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Phosphoric acid

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Phosphoric acid?

Phosphoric acid is an investigational drug.

There have been 6 clinical trials for Phosphoric acid. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2011.

The most common disease conditions in clinical trials are Pancreatic Neoplasms, Tooth Abrasion, and Gingival Recession. The leading clinical trial sponsors are CrystalGenomics, Inc., CSPC-NBP Pharmaceutical Co., Ltd., and Universidade Estadual Paulista Júlio de Mesquita Filho.

There is one US patent protecting this investigational drug and twelve international patents.

Recent Clinical Trials for Phosphoric acid
TitleSponsorPhase
Mucoderm® Versus CTG in the Treatment of Multiple Gingival Recessions Associated With Non-carious Cervical Lesion.Fundação de Amparo à Pesquisa do Estado de São PauloN/A
Mucoderm® Versus CTG in the Treatment of Multiple Gingival Recessions Associated With Non-carious Cervical Lesion.Universidade Estadual Paulista Júlio de Mesquita FilhoN/A
Effect of Curodont Repair on Color Change of White Spot LesionsCairo UniversityPhase 2

See all Phosphoric acid clinical trials

Clinical Trial Summary for Phosphoric acid

Top disease conditions for Phosphoric acid
Top clinical trial sponsors for Phosphoric acid

See all Phosphoric acid clinical trials

US Patents for Phosphoric acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Phosphoric acid   Start Trial Colloidal sols of antimony pentoxide in an aqueous medium and their preparation Laurel Industries, Inc. (Cleveland, OH)   Start Trial
Phosphoric acid   Start Trial Unique bone regeneration tricalcium phosphate The United States of America as represented by the Secretary of the Army (Washington, DC)   Start Trial
Phosphoric acid   Start Trial Imidazole ether compounds San-Apro Limited (Tokyo, JP)   Start Trial
Phosphoric acid   Start Trial Process of preparing non-cyclic polyalkylenepolyamines employing group VB metal catalysts The Dow Chemical Company (Midland, MI)   Start Trial
Phosphoric acid   Start Trial Drug delivery devices Vipont Pharmaceutical, Inc. (Fort Collins, CO)   Start Trial
Phosphoric acid   Start Trial Substituted propane-phosphinic acid compounds Ciba-Geigy Corporation (Ardsley, NY)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Phosphoric acid

Drugname Country Document Number Estimated Expiration Related US Patent
Phosphoric acid Canada 1099610 1995-08-18   Start Trial
Phosphoric acid Germany 2637185 1995-08-18   Start Trial
Phosphoric acid France 2321324 1995-08-18   Start Trial
Phosphoric acid United Kingdom 1563214 1995-08-18   Start Trial
Phosphoric acid Italy 1065149 1995-08-18   Start Trial
Phosphoric acid Japan S5229499 1995-08-18   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Boehringer Ingelheim
Express Scripts
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.